XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.2
SHARE-BASED PAYMENTS (Tables)
6 Months Ended
Jun. 30, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of the stock options granted under the Compensation Plan for the six months ended June 30, 2022 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate2.34 %
Expected life (in years)3.18
Expected volatility(1)
73.01 %
Expected dividend yield— %
Weighted average grant date fair value$5.05 
(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.
Schedule of Share-based Compensation, Stock Options, Activity
The summary of the Company’s stock options at June 30, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:
 Range of Exercise PricesNumber of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 2020
$1.70 - $15.61
1,609,087 $2.91 
 Granted
3.89 - 8.41
169,310 3.99 
 Exercised
 1.70 - 7.42
(775,814)2.95 
 Forfeited
1.76 - 5.91
(8,048)3.16 
 Expired
1.70 - 15.61
(51,653)8.14 
Outstanding, December 31, 2021
$1.70 - $8.41
942,882 $2.79 
 Granted
5.84 - 10.03
109,328 6.50 
 Exercised
1.70 - 5.18
(160,252)2.45 
 Forfeited
3.89 - 6.47
(3,385)5.78 
 Expired2.35 (15,506)2.35 
Outstanding, June 30, 2022
$1.70 - $10.03
873,067 $3.31 2.34$1,584 
Exercisable, June 30, 2022
$1.70 - $7.14
721,496 $2.79 1.92$1,544 
The summary of the Company’s non-vested stock options at June 30, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested, December 31, 2020403,990 $0.94 
 Granted169,310 2.06 
 Vested(351,934)1.23 
 Forfeited(8,049)1.60 
Non-vested, December 31, 2021213,317 $1.34 
 Granted109,328 5.05 
 Vested(167,689)1.12 
 Forfeited(3,385)5.00 
Non-vested, June 30, 2022151,571 $4.17 
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
The summary of the Company’s non-vested RSUs at June 30, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested, December 31, 20201,094,056 $1.98 
 Granted441,241 3.89 
 Vested(635,233)1.94 
Non-vested, December 31, 2021900,064 $2.94 
 Granted354,406 6.59 
 Vested(518,856)2.93 
 Forfeited(42,082)5.34 
Non-vested, June 30, 2022693,532 $4.66 
The summary of the Company’s SARs at June 30, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:
 Number of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 20201,720,623 $2.92 
Exercised(48,201)2.92 
Outstanding, December 31, 20211,672,422 $2.92 
 Granted833,315 6.47 
 Exercised(6,730)2.92 
 Forfeited(34,921)5.79 
Outstanding, June 30, 20222,464,086 $4.08 2.55$3,301
Exercisable, June 30, 20221,092,143 $2.92 1.56$2,173

The summary of the Company’s non-vested SARs at June 30, 2022 and December 31, 2021, respectively, and the changes for the fiscal periods ending on those dates, are presented below:
 Number of SharesWeighted Average Grant Date Fair Value
Non-vested, December 31, 20201,720,623 $1.25 
 Vested(1,147,074)1.27 
Non-vested, December 31, 2021573,549 $1.19 
 Granted833,315 3.99 
 Forfeited(34,921)4.05 
Non-vested, June 30, 20221,371,943 $2.83 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The components of share-based compensation are as follows:
Three months ended
June 30,
Six months ended
June 30,
2022202120222021
Recognized expense
Stock options$109 $37 $141 $240 
RSU awards(1)
488 390 972 753 
SARs550 62 896 197 
Total recognized expense$1,147 $489 $2,009 $1,190 
(1)The fair value of the RSUs granted under the Compensation Plan for the six months ended June 30, 2022 and 2021 was estimated at the date of grant, using the stated market price on the NYSE American.
Share-based Payment Arrangement, Restricted Stock Unit, Activity The fair value of the SARs granted during the six months ended June 30, 2022 was estimated at the date of grant using a Monte Carlo simulation, with the following weighted average assumptions:
Risk-free interest rate1.68 %
Expected life (in years)(1)
4.98
Expected volatility(2)
72.81 %
Expected dividend yield— %
Weighted average grant date fair value$3.99 
(1)Monte Carlo analysis of SARs assumes employee suboptimal exercise at first vesting time for each tranche.
(2)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the SARs.